指南更新（2014年10月）：阿尔茨海默病及其他痴呆症患者治疗实践指南
Guideline Watch (October 2014): Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias.
作者信息
Rabins Peter V, Rovner Barry W, Rummans Teresa, Schneider Lon S, Tariot Pierre N
出版信息
Focus (Am Psychiatr Publ). 2017 Jan;15(1):110-128. doi: 10.1176/appi.focus.15106. Epub 2017 Jan 11.
Abstract
(Reprinted with permission from American Psychiatric Association, http://psychiatryonline.org/guidelines).
摘要
（经美国精神病学协会许可重印，http://psychiatryonline.org/guidelines）
相似文献
1
Guideline Watch (October 2014): Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias.指南更新（2014年10月）：阿尔茨海默病及其他痴呆症患者治疗实践指南
Focus (Am Psychiatr Publ). 2017 Jan;15(1):110-128. doi: 10.1176/appi.focus.15106. Epub 2017 Jan 11.
2
The American Psychiatric Association Practice Guidelines for the Psychiatric Evaluation of Adults: Guideline V. Assessment of Cultural Factors.美国精神病学协会《成人精神病学评估实践指南：指南V.文化因素评估》。
Focus (Am Psychiatr Publ). 2020 Jan;18(1):71-74. doi: 10.1176/appi.focus.18105. Epub 2020 Jan 24.
3
American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition.美国精神病学协会《阿尔茨海默病及其他痴呆症患者治疗实践指南》。第二版。
Am J Psychiatry. 2007 Dec;164(12 Suppl):5-56.
4
The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia.美国精神病学协会《精神分裂症患者治疗实践指南》。
Focus (Am Psychiatr Publ). 2020 Oct;18(4):493-497. doi: 10.1176/appi.focus.18402. Epub 2020 Nov 5.
5
Neuropsychological Correlates of Behavioral Symptoms in Alzheimer's Disease, Frontal Variant of Frontotemporal, Subcortical Vascular, and Lewy Body Dementias: A Comparative Study.阿尔茨海默病、额颞叶痴呆额叶变异型、皮质下血管性痴呆和路易体痴呆行为症状的神经心理学关联：一项比较研究。
Focus (Am Psychiatr Publ). 2016 Oct;14(4):516-522. doi: 10.1176/appi.focus.140407. Epub 2016 Oct 7.
6
Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. American Psychiatric Association.阿尔茨海默病及其他老年期痴呆患者治疗实践指南。美国精神病学协会。
Am J Psychiatry. 1997 May;154(5 Suppl):1-39. doi: 10.1176/ajp.154.5.1.
7
The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder.美国精神病学协会酒精使用障碍患者药物治疗实践指南。
Focus (Am Psychiatr Publ). 2019 Apr;17(2):158-162. doi: 10.1176/appi.focus.17205. Epub 2019 Apr 10.
8
The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia.美国精神病学协会关于使用抗精神病药物治疗痴呆患者激越或精神病的实践指南。
Focus (Am Psychiatr Publ). 2017 Jan;15(1):81-84. doi: 10.1176/appi.focus.15107. Epub 2017 Jan 11.
9
Late-life dementia. Review of the APA guidelines for patient management.老年痴呆症。美国心理学会患者管理指南综述。
Geriatrics. 2000 Oct;55(10):55-60; quiz 62.
10
Alzheimer's disease. AMA Council on Scientific Affairs Reference Committee D.阿尔茨海默病。美国医学协会科学事务委员会参考委员会D。
J Okla State Med Assoc. 1998 Aug;91(5):298-306.
引用本文的文献
1
MiRNA-501-3p and MiRNA-502-3p: A promising biomarker panel for Alzheimer's disease.微小RNA-501-3p和微小RNA-502-3p：一种有前景的阿尔茨海默病生物标志物组合
Clin Transl Med. 2025 Jul;15(7):e70389. doi: 10.1002/ctm2.70389.
2
Rapid health technology assessment of galantamine for the treatment of Alzheimer's disease: A review.加兰他敏治疗阿尔茨海默病的快速卫生技术评估：一项综述
Medicine (Baltimore). 2025 Jun 6;104(23):e42744. doi: 10.1097/MD.0000000000042744.
3
Applying recommendations for diagnostic disclosure of mild cognitive impairment and dementia: Practical guidance for clinicians.应用轻度认知障碍和痴呆诊断信息披露的建议：临床医生实用指南。
Alzheimers Dement. 2025 Jan;21(1):e14200. doi: 10.1002/alz.14200. Epub 2024 Dec 30.
4
Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care.阿尔茨海默病协会关于疑似阿尔茨海默病及相关疾病的诊断评估、检测、咨询与信息披露的临床实践指南（DETeCD - ADRD）：初级保健建议执行摘要
Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14333.
5
Behavioral symptoms and treatment challenges for patients living with dementia: Hospice clinician and caregiver perspectives.痴呆症患者的行为症状及治疗挑战：临终关怀临床医生和护理人员的观点
J Am Geriatr Soc. 2025 Apr;73(4):1094-1104. doi: 10.1111/jgs.19320. Epub 2024 Dec 16.
6
Effectiveness of Vortioxetine Treatment on Depression and Cognitive Functions in Patients with Alzheimer's Disease: A 12-Month, Retrospective, Observational Study.伏硫西汀治疗阿尔茨海默病患者抑郁及认知功能的有效性：一项为期12个月的回顾性观察研究。
J Pers Med. 2024 Aug 29;14(9):918. doi: 10.3390/jpm14090918.
7
Defining a clinically meaningful within-patient change threshold for the Cohen-Mansfield Agitation Inventory in Alzheimer's dementia.确定阿尔茨海默病性痴呆患者中Cohen-Mansfield激越量表具有临床意义的患者内变化阈值。
Front Neurol. 2024 Jul 23;15:1379062. doi: 10.3389/fneur.2024.1379062. eCollection 2024.
8
The effectiveness of emotion-oriented approaches on psychological outcomes and cognitive function in older adults: A meta-analysis of randomised controlled trials.情绪导向方法对老年人心理结果和认知功能的影响：随机对照试验的荟萃分析。
J Glob Health. 2024 Jun 28;14:04123. doi: 10.7189/jogh.14.04123.
9
Dementia Ideal Care: Ecosystem Map of Best Practices and Care Pathways Enhanced by Technology and Community.痴呆症理想照护：通过技术和社区增强的最佳实践和照护路径生态系统图谱。
J Alzheimers Dis. 2024;100(1):87-117. doi: 10.3233/JAD-231491.
10
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial.一项实用的、多中心的、双盲、安慰剂对照随机试验，旨在评估米氮平和卡马西平在阿尔茨海默病伴激越行为患者中的安全性、临床疗效和成本效益：HTA-SYMBAD 试验。
Health Technol Assess. 2023 Oct;27(23):1-108. doi: 10.3310/VPDT7105.
Zotero 插件